MedPath

PF-06266047

Generic Name
PF-06266047

A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2015-09-03
Last Posted Date
2016-06-24
Lead Sponsor
Pfizer
Target Recruit Count
25
Registration Number
NCT02539550
Locations
🇧🇪

Pfizer Clinical Research Unit, Bruxelles, Belgium

© Copyright 2025. All Rights Reserved by MedPath